Protein Kinase Inhibitors: all 15,766 studies that test it

Page 148 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.

• Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaStatus unknownNCT00489944Phase 2
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast CancerStatus unknownNCT00486668Phase 3
• Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With SunitinibCompletedNCT00486538Phase 2
• Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic CancerStatus unknownNCT00486460Phase 3
• Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or LymphomaCompletedNCT00486135Phase 1
• Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid TumorsCompletedNCT00485719Phase 1
• Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00483366Phase 1
• A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic MelanomaCompletedNCT00483301Phase 2
• Effect of LY333531 on Vascular and Neural FunctionsCompletedNCT00482976Phase 2
• Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00482755Phase 2
• Nilotinib as First-line Treatment of Ph+ CML in Early Chronic PhaseCompletedNCT00481052Phase 2
• A Study of Neoadjuvant Sutent for Patients With Renal Cell CarcinomaTerminatedNCT00480935Phase 2
• A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT00480584Phase 1
• Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney RemovalCompletedNCT00480389Phase 2
• Efficacy and Safety of Imatinib in SclerodermaCompletedNCT00479934Phase 2
• Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOXCompletedNCT00479583Phase 1
• Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034CompletedNCT00478725Phase 1
• A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00478634Phase 1
• Sorafenib With TACE to Treat Hepatocellular CarcinomaCompletedNCT00478374Phase 1
• Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)CompletedNCT00478114Phase 3
• Iressa as Second Line Therapy in Advanced NSCLC-AsiaCompletedNCT00478049Phase 3
• Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCompletedNCT00475956Phase 1
• A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced MalignanciesTerminatedNCT00475917Phase 1
• Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.CompletedNCT00474864Phase 2
• Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and IrinotecanTerminatedNCT00473616Phase 1
• Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
• Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus SorafenibTerminatedNCT00473486Phase 1/2
• Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic BreastTerminatedNCT00473005Phase 1
• Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem GliomaCompletedNCT00472017Phase 1
• Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant RecipientsCompletedNCT00470665Phase 3
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00470197Phase 1
• Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic SteatohepatitisCompletedNCT00470171Phase 2
• Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
• B-Lymphocyte Immunotherapy in Islet TransplantationTerminatedNCT00468442Phase 2
• Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00467194Phase 1
• Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer PatientsCompletedNCT00466466Phase 1
• Phase II Trial of Tarceva in Patients With Non-Small Cell Lung CancerStatus unknownNCT00466284Phase 2
• Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung CancerCompletedNCT00466232Phase 1
• Efficacy of RAD001 in Breast Cancer Patients With Bone MetastasesStatus unknownNCT00466102Phase 2
• Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung CancerStatus unknownNCT00466089Phase 2
• Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)CompletedNCT00464919Phase 2
• Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)CompletedNCT00464633Phase 2
• Strategies to Improve Islet SurvivalCompletedNCT00464555Phase 2
• Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant PatientsCompletedNCT00464399Phase 3
• Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaTerminatedNCT00464113Phase 1
• AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid MalignanciesActive, not recruitingNCT00463814Phase 1
• Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)CompletedNCT00462995Phase 2
• GW572016 In Patients With Advanced Or Metastatic Breast CancerCompletedNCT00462956Phase 1
• Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsCompletedNCT00462553Phase 1
• MONET1-MOtesanib NSCLC Efficacy and Tolerability StudyTerminatedNCT00460317Phase 3
• Study of XL418 in Adults With Solid TumorsSuspendedNCT00460278Phase 1
• Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal CancerTerminatedNCT00459901Phase 2
• Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck CancerCompletedNCT00458978Phase 2
• Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
• RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMCompletedNCT00457964Phase 1/2
• Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAMCompletedNCT00457808Phase 2
• Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) PatientsCompletedNCT00457119Phase 1
• Sorafenib in BAC or Never-Smokers With Lung AdenocarcinomaCompletedNCT00456716Phase 2
• First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never SmokerCompletedNCT00455936Phase 3
• Ph II Study of Perifosine Plus Gleevec for Patients With GISTCompletedNCT00455559Phase 2
• INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer PatientsWithdrawnNCT00455039Phase 1/2
• AZD8330 First Time in Man in Patients With Advanced MalignanciesCompletedNCT00454090Phase 1
• A Study of Enzastaurin in Patients With LeukemiaCompletedNCT00452257Phase 1
• Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00452218Phase 1
• Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for ChemotherapyTerminatedNCT00452075Phase 2
• Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic SyndromesCompletedNCT00451997Phase 2
• Phase I/II Study of Neoadjuvant Lapatinib in Breast CancerCompletedNCT00450892Phase 1/2
• Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00450879Phase 1
• Sirolimus in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00450320Phase 1
• Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric CancerStatus unknownNCT00450203Phase 2/3
• Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous CycleStatus unknownNCT00449514Not applicable
• Drug Interaction Study of Sorafenib and Rapamycin in Advanced MalignanciesCompletedNCT00449280Phase 1
• Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid TumorsCompletedNCT00448786Phase 1
• A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal CancerCompletedNCT00448721Phase 2
• Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney CancerCompletedNCT00448149Phase 1/2
• Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)CompletedNCT00446381Not applicable
• Safety Study of RAD001 to Treat Patients With Metastatic Kidney CancerCompletedNCT00446368Phase 2
• Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid MalignanciesCompletedNCT00446342Phase 1
• Effect of a Proton Pump Inhibitor on Gleevec® in Healthy VolunteersCompletedNCT00446004Phase 1
• Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerCompletedNCT00445042Phase 2
• Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell CarcinomaCompletedNCT00444314Phase 2
• Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)CompletedNCT00444015Phase 1
• Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00443976Phase 1
• Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant PatientsCompletedNCT00443937Phase 4
• Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With ImatinibCompletedNCT00441155Phase 1
• Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00440414Phase 3
• Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's LymphomaCompletedNCT00440388Phase 2
• Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal FibrosisStatus unknownNCT00440349Phase 2
• A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single DoseCompletedNCT00439881Phase 1
• A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)CompletedNCT00437437Phase 1
• A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver DysfunctionCompletedNCT00437424Phase 1
• Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer PatientsCompletedNCT00437372Phase 1
• Sorafenib in Treating Patients With Advanced Solid TumorsTerminatedNCT00436579Phase 1
• ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerCompletedNCT00436072Phase 1
• A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)CompletedNCT00435669Phase 1
• Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
• Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606CompletedNCT00434486Phase 1
• Safety of Everolimus and Pemetrexed in Lung Cancer PatientsCompletedNCT00434174Phase 1
• Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy ParticipantsCompletedNCT00433485Phase 1
• Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian CancerCompletedNCT00431054Phase 1

← Protein Kinase Inhibitors overview